Schizophrenia omega 3 fatty acid: NICE medicine-related evidence summary

Posted on October 14, 2013 by SONHSLKS

NICE has published the following medicine related – ‘Evidence summary’
–  Unlicensed/off-label medicines – Schizophrenia: omega-3 fatty acid medicines  (ESUOM19)
Summary:  The randomised controlled trial (RCT) evidence for using omega-3 fatty acid medicines in people with schizophrenia is limited and the results are not consistent.

Details: http://www.nice.org.uk/mpc/evidencesummariesunlicensedofflabelmedicines/ESUOM19.jsp

Filed under: Adult Mental Health, CAMHS, Older Peoples Mental Health | Tagged: , , | Leave a comment »

Recent JAMA article on Omega-3 Augmentation of Sertraline in Treatment of Depression

Posted on November 9, 2009 by SONHSLKS

Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease.  This study investigates if omega-3 improves the response to sertraline in patients with major depression and coronary heart disease (CHD). 

Download the article here: http://jama.ama-assn.org/cgi/content/full/302/15/1651

Filed under: Current Awareness, Health Management, Knowledge Service | Tagged: , , | Leave a comment »